Plasmatech Biopharmaceuticals Inc (NASDAQ:PTBI) Raises $10 Million Financing

Plasmatech Biopharmaceuticals Inc (NASDAQ:PTBI) is one of the leading biopharmaceutical companies in the country with a primary focus on gene therapy and advancing cell therapy. As per the reports, the company has closed an equity funding worth as much as $10 million at $8 per share for 125,000 shares and warrants to buy 625,000 shares […]